Evaluation of the shed and spread of infectious bovine rhinotracheitis, parainfluenza-3 and bovine respiratory syncytial virus in young calves post-intranasal vaccination
The Bovine Practitioner · 2026-09-25 · 60 (2) · 32-40
DOI: 10.21423/bpj20269459 ↗Abstract
Intranasal vaccines are critical for early prevention of respiratory diseases in neonatal calves; however, concerns remain regarding potential transmission of vaccine virus strains to unvaccinated commingled animals, particularly in high-stress environments where vaccination history may be unknown. This study evaluated the presence, duration and shedding of infectious bovine rhinotracheitis (IBR), parainfluenza virus type 3 (PI3), and bovine respiratory syncytial virus (BRSV) in nasal secretions of intranasally vaccinated calves and transmission to commingled unvaccinated controls. Three commercially available intranasal vaccines, Inforce 3® (Zoetis), Nasalgen® 3-PMH (Merck), and PrimeLine® IN5 (Huvepharma), were evaluated. Holstein-cross, mixed-sex, colostrum-deprived calves, seronegative and PCR-negative for IBR, PI3 and BRSV, were enrolled. Blood samples were collected on days 0 and 21 to measure antibody titers using viral serum neutralization assays. Nasal swabs were collected daily from days 0 to 21 and analyzed by PCR for IBR, PI3 and BRSV. Nasal swabs were also tested for Histophilus somni by PCR to assess prevalence. Calves were randomly assigned to 4 groups housed in separate biosafety level 2 rooms. Each vaccine group contained commingled, inoculated and non-inoculated calves. A fourth sentinel group was monitored for wild-type virus or biosecurity breaches. Intranasal vaccination resulted in detectable virus in nasal secretions and transmission to commingled non-inoculated calves. Seroconversion in inoculated and non-inoculated calves confirmed vaccine virus shedding and pen-level spread. These findings demonstrate that intranasal vaccine strains can complicate diagnostic interpretation during respiratory disease investigations, underscoring the importance of vaccination history when distinguishing vaccine-derived from wild-type viruses in clinical and research settings.
EUVIMED